Evidence map›Paper›PMID 39386275›Full record

ArticleCanadian journal of kidney health and disease2024

An Environmental Scan of Canadian Kidney Transplant Programs for the Management of Patients With Graft Failure: A Research Letter.

Anita Slominska, Kathleen Gaudio, M Khaled Shamseddin, Ngan N Lam, Julie Ho, Amanda Vinson, Rahul Mainra, Stephanie Hoar, Marie-Chantal Fortin, S Joseph Kim and 5 more

Abstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anita SlominskaMetabolic Disorders and Complications, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Kathleen GaudioMetabolic Disorders and Complications, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
M Khaled ShamseddinDivision of Nephrology, Department of Medicine, Queen's University, Kingston, ON, Canada.
Ngan N LamDivisions of Transplant Medicine and Nephrology, Department of Medicine, Cumming School of Medicine, University of Calgary, AB, Canada.ORCID https://orcid.org/0000-0002-0129-7091
Julie HoDepartment of Internal Medicine, University of Manitoba, Winnipeg, Canada.ORCID https://orcid.org/0000-0002-8342-9093
Amanda VinsonDivision of Nephrology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.ORCID https://orcid.org/0000-0002-9345-5252
Rahul MainraDivision of Nephrology, Department of Medicine, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
Stephanie HoarDivision of Nephrology, Faculty of Medicine, University of Ottawa, ON, Canada.
Marie-Chantal FortinCentre de Recherche, Centre Hospitalier de l'Université de Montréal, QC, Canada.ORCID https://orcid.org/0000-0002-8437-0556
S Joseph KimDivision of Nephrology and Kidney Transplant Program, Toronto General Hospital, University Health Network, ON, Canada.
Sacha DeSerresDivision of Nephrology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, Canada.
G V Ramesh PrasadDivision of Nephrology and Kidney Transplant Program, St. Michael's Hospital, Toronto, ON, Canada.ORCID https://orcid.org/0000-0003-1576-7696
Matthew A WeirDivision of Nephrology, Department of Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada.
Marcelo CantarovichMetabolic Disorders and Complications, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Shaifali SandalMetabolic Disorders and Complications, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.ORCID https://orcid.org/0000-0003-1941-0598

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Kidney transplant recipients with graft failure (KTR-GF) and those with a failing graft are an increasingly prevalent group of patients. Their clinical management is complex, and outcomes are worse than transplant naïve patients on dialysis. In 2023, the Kidney Disease: Improving Global Outcomes (KDIGO) organization reported findings from a controversies conference and identified several clinical practice priorities for KTR-GF. Objective: As an exercise in needs assessment, we aimed to collate and summarize current practices in adult Canadian kidney transplant programs around these KDIGO-identified clinical practice priorities. Design: Environmental scan followed by content analysis. Setting: Canadian adult kidney transplant programs. Measurements: We categorized the themes of our content analysis around 7 clinical practice priorities: (1) determining prognosis and kidney failure trajectory; (2) immunosuppression management; (3) management of medical complications; (4) preparing for return to dialysis; (5) evaluation and listing for re-transplantation; (6) management of psychological effects; and (7) transition to supportive care. Methods: We solicited documents that identified each program's current care practices for KTR-GF or patients with a failing graft, including policies, procedures, pathways, and protocols. A content analysis of documents and informal correspondence (email or telephone conversations) was done to extract information surrounding the 7 practice priorities. Results: Of the 18 programs contacted, 12 transplant programs participated in this study and a document from a provincial organization (where 2 non-responding programs are located) was procured and included in this analysis. Overall, practice gaps and discrepancies were noted. Many participants highlighted the lack of evidence or consensus to guide the management of KTR-GF as the key reason. Immunosuppression management was the most frequently addressed priority. Six programs and the provincial document recommended a nuanced approach to immunosuppressant management based on clinical factors and re-transplant candidacy. Two programs used the Kidney Failure Risk Equation and eGFR to determine referral trajectories and prepare patients for return to dialysis. Exact processes outlining medical management during the transition were not found except for nephrectomy indications and in 1 program that has a specific transition clinic for KTR-GF. All programs have a formal or informal policy that KTR-GF should be assessed for re-transplantation. Referrals for psychological support and transition to supportive care were made on a case-by-case basis. Limitations: Our environmental scan was at risk of non-response bias and restricted to transplant programs. Kidney clinics and dialysis units may have relevant policies and procedures that were not examined. Conclusion: The findings from our environmental scan suggest gaps in care and potential areas for quality improvement, including a lack of multidisciplinary care, structured dialysis preparation and psychological support. There is also a need to prioritize research that generates evidence to guide the management of KTR-GF and contributes to the aim of developing clinical practice guidelines.

Indexed as

content analysisenvironmental scangraft failurekidney transplantationpsychosocial supporttransitions of care

Identifiers

PMID39386275
PMCPMC11462417

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.